Orphan SA :: Products under Development :: OrBec

    1. Order Products

    2. Products Under Development
      What is OrBec

      OrBec® is an investigational therapy (i.e., orBec® has not received marketing authorization/regulatory approval in any territory) that has been evaluated in Phase 1, 2 and 3 clinical trials and will be the subject of a confirmatory, Phase 3 study for the treatment of acute GI GVHD. 

       

      PDF Document   OrBec® Access Form (PDF format)

      PDF Document   OrBec®Perscribing Information (PDF format)

      PDF Document   Adverse Event Reporting Form(PDF format)
       
    2. Disclaimer: The information and literature on this web site is provided for general information only. It should not be relied on without reviewing original copies of any citations or obtaining specific advice from appropriate experts or health professionals. No warranty is made that this information is complete and accurate. Orphan SA will not be liable for any loss or damage from using the information. Certain (hypertext) links on the Orphan SA site are to web sites that may not be controlled by Orphan SA. When you activate any of these you will leave the Orphan SA site. Orphan SA has no control over and accepts no responsibility or liability in respect of the material of any web site which is not controlled by Orphan SA.